Decrease in Lipoatrophy in a Pilot Study Using a Short-Term Treatment Interruption Strategy for 48 Weeks in São Paulo,Brazil

Abstract

Get full access to this article

View all access options for this article.

References

Lifson

, Belloso

, Davey

et al. Development of diagnostic criteria for serious non-AIDS events in HIV clinical trials. HIV Clin Trials, 11:205–219.

Pirillo

, Palmisano

, Pellegrini

et al. Nonnucleoside reverse transcriptase inhibitor concentrations during treatment interruptions and the emergence of resistance: A substudy of the ISS-PART Trial. AIDS Res Hum Retroviruses, 2010; 26:541–545.

Durnin

, Womersley

. Body fat assessed from total body density and its estimation from skinfold thickness: measurements on 481 men and women aged from 16 to 72 years. Br J Nutr, 1974; 32:77–97.

Ribaudo

, Haas

, Tierney

et al. Pharmacogenetics of plasma efavirenz exposure after treatment discontinuation: an Adult AIDS Clinical Trials Group Study. Clin Infect Dis, 2006; 42:401–407.

Cohen

, Colson

, Sheble-Hall

, McLaughlin

, Morse

. Pilot study of a novel short-cycle antiretroviral treatment interruption strategy: 48-week results of the five-days-on, two-days-off (FOTO) study. HIV Clin Trials, 2007; 8:19–23.

Reynolds

, Kityo

, Hallahan

et al. A randomized, controlled, trial of short cycle intermittent compared to continuous antiretroviral therapy for the treatment of HIV infection in Uganda. PLoS One, 2010; 5:e10307.